A detailed history of Two Sigma Investments, LP transactions in Alector, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 262,522 shares of ALEC stock, worth $674,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
262,522
Previous 302,138 13.11%
Holding current value
$674,681
Previous $1.37 Million 10.65%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.34 - $6.58 $171,933 - $260,673
-39,616 Reduced 13.11%
262,522 $1.23 Million
Q2 2024

Aug 14, 2024

SELL
$4.19 - $6.23 $261,837 - $389,318
-62,491 Reduced 17.14%
302,138 $1.37 Million
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $979,146 - $1.39 Million
172,082 Added 89.37%
364,629 $2.2 Million
Q4 2023

Feb 14, 2024

BUY
$3.77 - $8.39 $339,737 - $756,073
90,116 Added 87.98%
192,547 $1.54 Million
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $963,482 - $1.62 Million
-185,285 Reduced 64.4%
102,431 $663,000
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $460,531 - $623,210
-78,589 Reduced 21.45%
287,716 $1.73 Million
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $677,535 - $1.14 Million
115,818 Added 46.24%
366,305 $2.27 Million
Q4 2022

Feb 14, 2023

SELL
$6.88 - $9.55 $199,148 - $276,434
-28,946 Reduced 10.36%
250,487 $2.31 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $149,115 - $240,332
18,207 Added 6.97%
279,433 $2.64 Million
Q2 2022

Aug 15, 2022

SELL
$7.65 - $14.24 $149,855 - $278,947
-19,589 Reduced 6.98%
261,226 $2.65 Million
Q1 2022

May 16, 2022

SELL
$13.02 - $20.78 $873,277 - $1.39 Million
-67,072 Reduced 19.28%
280,815 $4 Million
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $143,209 - $189,021
7,401 Added 2.17%
347,887 $7.18 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $7.37 Million - $13.4 Million
340,486 New
340,486 $7.77 Million
Q1 2021

May 17, 2021

SELL
$14.84 - $22.23 $927,500 - $1.39 Million
-62,500 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $3.81 Million - $6.76 Million
-404,990 Reduced 86.63%
62,500 $946,000
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $3 Million - $7.1 Million
284,586 Added 155.59%
467,490 $4.93 Million
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $3.14 Million - $4.75 Million
143,601 Added 365.37%
182,904 $4.47 Million
Q1 2020

May 15, 2020

BUY
$16.25 - $35.28 $638,673 - $1.39 Million
39,303 New
39,303 $948,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.